Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Squamous Cell Carcinoma of the Head or Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03194373
What this trial is testing

Phase II Trial Evaluating the Efficacy of Palbociclib in Combination With Carboplatin for the Treatment of Unresectable Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
University of Michigan Rogel Cancer Center 21
Not applicableStudy completedNCT04672772
What this trial is testing

Cetuximab Plus Paclitaxel as First Line for Recurrent and/or Metastatic SCCHN: Real World Data.

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello 531
Testing effectiveness (Phase 2)Active Not RecruitingNCT03813836
What this trial is testing

Phase II Trial of Pembrolizumab in Recurrent or Metastatic HNSCC

Who this might be right for
Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
University College, London 63
Early research (Phase 1)Looking for participantsNCT06868433
What this trial is testing

TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

Who this might be right for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+20 more
Emory University
Testing effectiveness (Phase 2)UnknownNCT06078657
What this trial is testing

IBI110 Combined With Sintilimab in Second-line Advanced or Metastatic Esophageal Squamous Cell Carcinoma(ESCC)

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)PD-1 Inhibitors
The First Affiliated Hospital of Zhengzhou University 46
Testing effectiveness (Phase 2)Ended earlyNCT04424641
What this trial is testing

A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumor(s)Prostate CancerEsophageal Cancer+5 more
Genmab 48
Testing effectiveness (Phase 2)Study completedNCT00004865
What this trial is testing

Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy

Who this might be right for
Head and Neck Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)UnknownNCT03913182
What this trial is testing

Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell CarcinomaApatinibRecurrence+1 more
Shanghai Chest Hospital 39
Testing effectiveness (Phase 2)Study completedNCT03226756
What this trial is testing

Nivolumab in Recurrent and/or Metastatic SCCHN

Who this might be right for
Recurrent and/or Metastatic Platinum-refractory SCCHN
UNICANCER 351
Large-scale testing (Phase 3)Study completedNCT00460265
What this trial is testing

Study of Panitumumab Efficacy in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Who this might be right for
Recurrent and/or Metastatic Head and Neck Cancer
Amgen 658
Early research (Phase 1)Active Not RecruitingNCT04460937
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers

Who this might be right for
Clinical Stage III Esophageal Adenocarcinoma AJCC v8Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8+56 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT00090337
What this trial is testing

Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck Cancer

Who this might be right for
Head and Neck CancerPain
Memorial Sloan Kettering Cancer Center 73
Testing effectiveness (Phase 2)Study completedNCT02797964
What this trial is testing

A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer

Who this might be right for
Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)
Sierra Oncology LLC - a GSK company 107
Not applicableStudy completedNCT00896675
What this trial is testing

Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 352
Testing effectiveness (Phase 2)Active Not RecruitingNCT02955290
What this trial is testing

CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer

Who this might be right for
Advanced Head and Neck Squamous Cell CarcinomaLung Non-Small Cell CarcinomaMetastatic Lung Non-Small Cell Carcinoma+13 more
Roswell Park Cancer Institute 51
Not applicableLooking for participantsNCT07546383
What this trial is testing

A Study Investigating the Efficacy and Safety of the Combination of Iparomlimab and Tuvonralimab With or Without Chemotherapy in Second-line and Subsequent Treatments for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
The Second Affiliated Hospital of Hainan Medical University 32
Testing effectiveness (Phase 2)Looking for participantsNCT06857279
What this trial is testing

A Phase II Clinical Study to Evaluate HLX43 in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Carcinoma of Head and/or Neck
Shanghai Henlius Biotech 167
Testing effectiveness (Phase 2)Ended earlyNCT04242173
What this trial is testing

Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC

Who this might be right for
Cutaneous Squamous Cell CarcinomaCutaneous Squamous Cell Carcinoma of the Head and Neck
H. Lee Moffitt Cancer Center and Research Institute 3
Early research (Phase 1)Study completedNCT03666273
What this trial is testing

Phase 1 Study of BAY1905254 - An Early Clinical Research Study to Evaluate a New Drug Called Bapotulimab (BAY1905254) in the Expansion Cohort in Combination With Pembrolizumab in Head and Neck Cancer That Has Returned or is Discovered to be Metastatic and is Expressing PDL1.

Who this might be right for
Advanced Solid TumorHead and Neck Squamous Cell Carcinoma
Bayer 60
Testing effectiveness (Phase 2)Ended earlyNCT00646659
What this trial is testing

Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery

Who this might be right for
Head and Neck Cancer
European Organisation for Research and Treatment of Cancer - EORTC 47
Next Page
40
4